Melanie Fawaz Alazzam1, Azmi Mohammad-Ghaleb Darwazeh1, Yazan Mansour Hassona2, Yousef Saleh Khader3. 1. Department of Oral Medicine and Oral Surgery, School of Dentistry, Jordan University of Science and Technology, Irbid, Jordan. 2. Department of Oral and Maxillofacial Surgery, Oral Medicine and Periodontology, School of Dentistry, University of Jordan, Amman, Jordan. 3. Department of Public Health, School of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Abstract
BACKGROUND: Dental offices can be useful to screen and identify patients at risk of developing diabetes mellitus (DM) using risk prediction tools. The Finnish Diabetes Risk Score (FINDRISC) is a validated, questionnaire-based tool used to predict the 10-year risk of developing type II DM. OBJECTIVES: To determine the 10-year DM risk among Jordanians using the FINDRISC questionnaire in a dental setting. MATERIALS AND METHODS: Participants attending two university dental teaching centres between March 2017 and February 2018 were interviewed using an Arabic translated version of the FINDRISC questionnaire. Anthropometrics including weight, height, waist circumference (WC) and body mass index (BMI) were recorded. Random capillary blood glucose level was measured for each participant. Statistical analysis was done using Chi-square and independent t-tests. RESULTS: A total of 1,247 (436 males and 811 females) participants were included. As defined by BMI, 1,012 (81.2%) participants were either overweight or obese. Abdominal adiposity as determined by WC was seen in 738 (59.2%) participants. The mean (± SD) FINDRISC score for females (11.3 ± 4.3) was significantly higher (P = 0.001) than males (10.4 ± 4.9). After age adjustment, more females were in the high-risk categories (FINDRISC ≥ 15) compared with males. This trend was seen among all age groups, but was statistically significant in the older age groups; 55-64 years (P = 0.037) and ≥ 65 years (P = 0.004). CONCLUSION: In a developing Middle Eastern country such as Jordan, almost half of Jordanians attending university dental clinics are at a moderate to high risk of developing type II DM in 10 years. The risk of DM should be considered in dental patients, particularly older females.
BACKGROUND: Dental offices can be useful to screen and identify patients at risk of developing diabetes mellitus (DM) using risk prediction tools. The Finnish Diabetes Risk Score (FINDRISC) is a validated, questionnaire-based tool used to predict the 10-year risk of developing type II DM. OBJECTIVES: To determine the 10-year DM risk among Jordanians using the FINDRISC questionnaire in a dental setting. MATERIALS AND METHODS: Participants attending two university dental teaching centres between March 2017 and February 2018 were interviewed using an Arabic translated version of the FINDRISC questionnaire. Anthropometrics including weight, height, waist circumference (WC) and body mass index (BMI) were recorded. Random capillary blood glucose level was measured for each participant. Statistical analysis was done using Chi-square and independent t-tests. RESULTS: A total of 1,247 (436 males and 811 females) participants were included. As defined by BMI, 1,012 (81.2%) participants were either overweight or obese. Abdominal adiposity as determined by WC was seen in 738 (59.2%) participants. The mean (± SD) FINDRISC score for females (11.3 ± 4.3) was significantly higher (P = 0.001) than males (10.4 ± 4.9). After age adjustment, more females were in the high-risk categories (FINDRISC ≥ 15) compared with males. This trend was seen among all age groups, but was statistically significant in the older age groups; 55-64 years (P = 0.037) and ≥ 65 years (P = 0.004). CONCLUSION: In a developing Middle Eastern country such as Jordan, almost half of Jordanians attending university dental clinics are at a moderate to high risk of developing type II DM in 10 years. The risk of DM should be considered in dental patients, particularly older females.
Authors: Justin B Echouffo-Tcheugui; Mary Mayige; Anthonia Okeoghene Ogbera; Eugene Sobngwi; Andre P Kengne Journal: Diabetes Res Clin Pract Date: 2012-09-10 Impact factor: 5.602
Authors: K Ajlouni; A Batieha; H Jaddou; Y Khader; N Abdo; M El-Khateeb; D Hyassat; D Al-Louzi Journal: Diabet Med Date: 2019-01-25 Impact factor: 4.359
Authors: Manjusha Kulkarni; Randi E Foraker; Ann M McNeill; Cynthia Girman; Sherita H Golden; Wayne D Rosamond; Bruce Duncan; Maria Ines Schmidt; Jaakko Tuomilehto Journal: Diabetes Obes Metab Date: 2017-05-22 Impact factor: 6.577
Authors: Azadeh Zabetian; Heval Mohamed Kelli; Justin B Echouffo-Tcheugui; K M Venkat Narayan; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2013-05-01 Impact factor: 5.602
Authors: Anne Jølle; Kristian Midthjell; Jostein Holmen; Jaakko Tuomilehto; Sven M Carlsen; Jonathan Shaw; Bjørn O Åsvold Journal: BMJ Open Diabetes Res Care Date: 2016-06-22
Authors: Nabil Sulaiman; Ibrahim Mahmoud; Amal Hussein; Salah Elbadawi; Salah Abusnana; Paul Zimmet; Jonathan Shaw Journal: BMJ Open Diabetes Res Care Date: 2018-03-29